🇺🇸 FDA
Pipeline program

gemcitabine

CAPPA-2

Phase 3 small_molecule terminated

Quick answer

gemcitabine for Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NORTHWEST BIOTHERAPEUTICS INC
Indication
Non-Small Cell Lung Cancer
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials